Gianluca Pettiti net worth and biography

Gianluca Pettiti Biography and Net Worth

Gianluca became Executive Vice President in January 2022, with responsibility for our Specialty Diagnostics, Life Sciences and Laboratory Products, and Genetic Sciences businesses, as well as our Chief Scientific Office and Quality/Regulatory function. Previously, he was Senior Vice President and President, Specialty Diagnostics, and in January 2021, he assumed additional responsibility for our clinical next-generation sequencing business. Gianluca joined the company through the acquisition of Life Technologies in 2014, where he was serving as President, Greater China. From 2015 through 2017, he led Thermo Fisher’s business in China, and became President, Biosciences, in 2018.

Gianluca began his career with General Electric and joined Life Technologies in 2006, serving in finance leadership roles in Europe before becoming Vice President and General Manager of the Latin America business in 2010 and assuming leadership of Greater China in 2013.

Gianluca earned a Master of Science degree in engineering from Politecnico di Torino in Italy. He served as a member of the Global Future Council on Health and Healthcare of the World Economic Forum from 2016 to 2018.

What is Gianluca Pettiti's net worth?: The estimated net worth of Gianluca Pettiti is at least $9.51 million as of August 30th, 2023. Mr. Pettiti owns 17,556 shares of Thermo Fisher Scientific stock worth more than $9,506,925 as of April 18th. This net worth evaluation does not reflect any other investments that Mr. Pettiti may own. Additionally, Mr. Pettiti receives a salary of $1,660,000.00 as EVP at Thermo Fisher Scientific. Learn More about Gianluca Pettiti's net worth.
How old is Gianluca Pettiti?: Mr. Pettiti is currently 45 years old. There are 5 older executives and no younger executives at Thermo Fisher Scientific. The oldest executive at Thermo Fisher Scientific is Mr. Stephen Williamson, Senior VP & CFO, who is 57 years old. Learn More on Gianluca Pettiti's age.
What is Gianluca Pettiti's salary?: As the EVP of Thermo Fisher Scientific Inc., Mr. Pettiti earns $1,660,000.00 per year. There are 3 executives that earn more than Mr. Pettiti. The highest earning executive at Thermo Fisher Scientific is Mr. Marc N. Casper, Chairman, President & CEO, who commands a salary of $5,080,000.00 per year. Learn More on Gianluca Pettiti's salary.
How do I contact Gianluca Pettiti?: The corporate mailing address for Mr. Pettiti and other Thermo Fisher Scientific executives is 168 Third Avenue, Waltham MA, 02451. Thermo Fisher Scientific can also be reached via phone at (781) 622-1000 and via email at [email protected]. Learn More on Gianluca Pettiti's contact information.
Has Gianluca Pettiti been buying or selling shares of Thermo Fisher Scientific?: Gianluca Pettiti has not been actively trading shares of Thermo Fisher Scientific during the last quarter. Most recently, Gianluca Pettiti sold 3,000 shares of the business's stock in a transaction on Wednesday, August 30th. The shares were sold at an average price of $557.77, for a transaction totalling $1,673,310.00. Following the completion of the sale, the executive vice president now directly owns 17,556 shares of the company's stock, valued at $9,792,210.12. Learn More on Gianluca Pettiti's trading history.
Who are Thermo Fisher Scientific's active insiders?: Thermo Fisher Scientific's insider roster includes Michael Boxer (SVP), Marc Casper (CEO), Peter Hornstra (CAO), Syed Jafry (VP), Michel Lagarde (EVP), Jim Manzi (Director), Gianluca Pettiti (EVP), Debora Spar (Director), Mark Stevenson (COO), and Stephen Williamson (CFO). Learn More on Thermo Fisher Scientific's active insiders.
Are insiders buying or selling shares of Thermo Fisher Scientific?: During the last twelve months, Thermo Fisher Scientific insiders bought shares 1 times. They purchased a total of 4 shares worth more than $2,104.60. During the last twelve months, insiders at the medical research company sold shares 14 times. They sold a total of 110,577 shares worth more than $59,726,166.22. The most recent insider tranaction occured on March, 12th when CEO Marc N Casper sold 10,000 shares worth more than $5,979,800.00. Insiders at Thermo Fisher Scientific own 0.3% of the company. Learn More about insider trades at Thermo Fisher Scientific.
Information on this page was last updated on 3/12/2024.

Gianluca Pettiti Insider Trading History at Thermo Fisher Scientific

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/30/2023	Sell	3,000	$557.77	$1,673,310.00	17,556
12/13/2022	Sell	4,975	$576.84	$2,869,779.00	16,450

Gianluca Pettiti Buying and Selling Activity at Thermo Fisher Scientific

Thermo Fisher Scientific Company Overview

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $541.78

$529.64

$544.69

50 Day Range

MA: $571.57

$538.73

$599.43

2 Week Range

Now: $541.78

$415.60

$603.82

Volume

2,075,782 shs

Average Volume

1,547,352 shs

Market Capitalization

$206.80 billion

P/E Ratio

35.07

Dividend Yield

0.28%

Beta

0.8

Biden’s $374B Giveaway Into This Sector

From DTI | Ad

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Gianluca Pettiti Biography and Net Worth

What is Gianluca Pettiti's net worth?

How old is Gianluca Pettiti?

What is Gianluca Pettiti's salary?

How do I contact Gianluca Pettiti?

Has Gianluca Pettiti been buying or selling shares of Thermo Fisher Scientific?

Who are Thermo Fisher Scientific's active insiders?

Are insiders buying or selling shares of Thermo Fisher Scientific?